BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35307301)

  • 1. Reirradiation for recurrent head and neck carcinoma using high-dose-rate brachytherapy: A multi-institutional study.
    Yamazaki H; Masui K; Suzuki G; Yoshida K; Nakamura S; Isohashi F; Kotsuma T; Takaoka Y; Tanaka E; Akiyama H; Ishibashi N
    Brachytherapy; 2022; 21(3):341-346. PubMed ID: 35307301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national surveillance study of the current status of reirradiation using brachytherapy in Japan.
    Yamazaki H; Masui K; Shimizu D; Suzuki G; Isohashi F; Yoshida K;
    Brachytherapy; 2021; 20(1):226-231. PubMed ID: 32888854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat re-irradiation with interstitial HDR-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.
    Kim JK; Hardy-Abeloos C; Purswani JM; Kamen E; Concert CM; Duckworth T; Tam M; Haas J; Rybstein M; Vaezi A; Jacobson A; Hu KS
    Brachytherapy; 2023; 22(4):503-511. PubMed ID: 36593130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations.
    Alterio D; Zaffaroni M; Bossi P; Dionisi F; Elicin O; Falzone A; Ferrari A; Jereczek-Fossa BA; Sanguineti G; Szturz P; Volpe S; Scricciolo M
    Radiol Med; 2023 Aug; 128(8):1007-1021. PubMed ID: 37415056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
    Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
    Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers.
    Mahantshetty U; Kashid SR; Mulye G; Gurram L; Engineer R; Chopra S; Ghosh J; Gulia S; Gupta S; Ghadi Y; A D; Kohle S; Kadam S; Menon S; Deodhar K; Maheshwari A; Ts S; Lewis S; Kalyani N; Shrivastava SK
    Brachytherapy; 2023; 22(6):753-760. PubMed ID: 37716821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
    Rudžianskas V; Inčiūra A; Vaitkus S; Padervinskis E; Rudžianskienė M; Kupčinskaitė-Noreikienė R; Saltonaitė L; Noreika A; Statnickaitė A; Juozaitytė E
    Medicina (Kaunas); 2014; 50(2):92-9. PubMed ID: 25172603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy.
    Hegde JV; Demanes DJ; Veruttipong D; Chin RK; Park SJ; Kamrava M
    Head Neck; 2018 Jul; 40(7):1524-1533. PubMed ID: 29573121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure.
    Mahé M; Beddok A; Goudjil F; Ala Eddine C; Bolle S; Champion L; Feuvret L; Herman P; Zefkili S; Choussy O; Le Tourneau C; Dendale R; Buvat I; Sauvaget E; Créhange G; Calugaru V
    Int J Radiat Biol; 2024; 100(1):79-86. PubMed ID: 37526368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
    Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
    J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes.
    Isohashi F; Yoshida K; Murakami N; Masui K; Ishihara S; Ohkubo Y; Kaneyasu Y; Kinoshita R; Kotsuma T; Takaoka Y; Tanaka E; Nagao A; Ogawa K; Yamazaki H
    Radiother Oncol; 2024 Jun; 195():110269. PubMed ID: 38583719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy.
    Rudzianskas V; Inciura A; Juozaityte E; Rudzianskiene M; Kubilius R; Vaitkus S; Kaseta M; Adliene D
    Acta Otorhinolaryngol Ital; 2012 Oct; 32(5):297-303. PubMed ID: 23326008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
    Beddok A; Maynadier X; Krhili S; Ala Eddine C; Champion L; Chilles A; Goudjil F; Zefkili S; Amessis M; Choussy O; Le Tourneau C; Buvat I; Créhange G; Carton M; Calugaru V
    Strahlenther Onkol; 2023 Oct; 199(10):901-909. PubMed ID: 37256301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.
    Nag S; Cano ER; Demanes DJ; Puthawala AA; Vikram B;
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1190-8. PubMed ID: 11483328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach-part I: prognostic factors and indications to treatment.
    Alterio D; Zaffaroni M; Bossi P; Dionisi F; Elicin O; Falzone A; Ferrari A; Jereczek-Fossa BA; Sanguineti G; Szturz P; Volpe S; Scricciolo M
    Radiol Med; 2024 Jan; 129(1):160-173. PubMed ID: 37731151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review.
    Tagliaferri L; Bussu F; Fionda B; Catucci F; Rigante M; Gambacorta MA; Autorino R; Mattiucci GC; Miccichè F; Placidi E; Balducci M; Galli J; Paludetti G; Kovacs G; Valentini V
    Tumori; 2017 Nov; 103(6):516-524. PubMed ID: 28291904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT).
    Zhong J; Brown S; Serra M; Shuttleworth P; Bownes P; Thompson C; Reed R; Reeves K; Dubec M; McHugh D; Eccles C; Chuter R; Tsang YM; Taylor NJ; West C; Buckley D; Scarsbrook A; Choudhury A; Hoskin P; Henry A
    BMJ Open; 2022 Nov; 12(11):e068580. PubMed ID: 36351720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
    Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
    Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
    Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY
    JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.